FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2990244562> ?p ?o ?g. }

• W2990244562 endingPage "100647" @default.
• W2990244562 startingPage "100647" @default.
• W2990244562 abstract "Thrombopoietin receptor agonists (TPO-RAs) are currently indicated for continuous treatment of chronic primary immune thrombocytopenia (ITP). However, there is growing evidence that TPO-RAs can also trigger sustained response in 10–30% of cases after treatment tapering and discontinuation. Therefore, at least for selected responding patients, it might be rational to plan TPO-RA interruption to exploit off-treatment response. Intriguingly, complete or partial responses with TPO-RAs are frequently observed when treatments are initiated early, suggesting that unknown immune-related mechanisms may be involved in this phenomenon. The sustained responses observed after interruption of TPO-RAs may be interpreted as a recovery of immunological tolerance; thus, the re-establishment of immunological equilibrium might be primarily responsible for the observed off-treatment effect. Importantly, these findings may indicate that anticipated TPO-RA usage can lead to improved responses, and that optimized tapering and interruption in selected patients can furthermore improve prognoses. On the base of this rationale, a series of real-life considerations have been generated by a panel of Experts to elucidate possible novel criteria and modalities to identify subgroups of patients who can benefit from tapering and/or discontinuation of TPO-RAs. Towards this aim, the results of a survey of ITP experts are herein reported, reflecting a snapshot of current real-life experience on early discontinuation of TPO-RA-based therapy. The present manuscript also highlights the importance of future translational studies on novel prognostic and predictive biomarkers that can stratify patients and facilitate the clinical choice for second-line treatment of ITP." @default.
• W2990244562 created "2019-12-05" @default.
• W2990244562 creator A5002133396 @default.
• W2990244562 creator A5005922904 @default.
• W2990244562 creator A5028356813 @default.
• W2990244562 creator A5035335560 @default.
• W2990244562 creator A5039006383 @default.
• W2990244562 creator A5066768069 @default.
• W2990244562 creator A5071210944 @default.
• W2990244562 creator A5075748907 @default.
• W2990244562 creator A5077344066 @default.
• W2990244562 creator A5080599868 @default.
• W2990244562 creator A5085901299 @default.
• W2990244562 date "2020-05-01" @default.
• W2990244562 modified "2023-10-14" @default.
• W2990244562 title "Tapering and discontinuation of thrombopoietin receptor agonists in immune thrombocytopenia: Real-world recommendations" @default.
• W2990244562 cites W1509820083 @default.
• W2990244562 cites W1556682722 @default.
• W2990244562 cites W1940859004 @default.
• W2990244562 cites W1969903307 @default.
• W2990244562 cites W1975300245 @default.
• W2990244562 cites W1984073642 @default.
• W2990244562 cites W1991437102 @default.
• W2990244562 cites W2007428429 @default.
• W2990244562 cites W2010176345 @default.
• W2990244562 cites W2012780133 @default.
• W2990244562 cites W2013946336 @default.
• W2990244562 cites W2023093390 @default.
• W2990244562 cites W2026485303 @default.
• W2990244562 cites W2033207183 @default.
• W2990244562 cites W2037982136 @default.
• W2990244562 cites W2038554277 @default.
• W2990244562 cites W2044772354 @default.
• W2990244562 cites W2052378439 @default.
• W2990244562 cites W2057964077 @default.
• W2990244562 cites W2059190713 @default.
• W2990244562 cites W2098728471 @default.
• W2990244562 cites W2101420481 @default.
• W2990244562 cites W2101821102 @default.
• W2990244562 cites W2119920607 @default.
• W2990244562 cites W2151165602 @default.
• W2990244562 cites W2153674764 @default.
• W2990244562 cites W2156817733 @default.
• W2990244562 cites W2179600628 @default.
• W2990244562 cites W2233823712 @default.
• W2990244562 cites W2312678770 @default.
• W2990244562 cites W2328749309 @default.
• W2990244562 cites W2342664814 @default.
• W2990244562 cites W2414381444 @default.
• W2990244562 cites W2476537069 @default.
• W2990244562 cites W2517229264 @default.
• W2990244562 cites W2547733445 @default.
• W2990244562 cites W2557392139 @default.
• W2990244562 cites W2563759828 @default.
• W2990244562 cites W2566591624 @default.
• W2990244562 cites W2586334726 @default.
• W2990244562 cites W2592103559 @default.
• W2990244562 cites W2593042614 @default.
• W2990244562 cites W2730640346 @default.
• W2990244562 cites W2734931922 @default.
• W2990244562 cites W2765458598 @default.
• W2990244562 cites W2768159876 @default.
• W2990244562 cites W2791522161 @default.
• W2990244562 cites W2791837202 @default.
• W2990244562 cites W2807732905 @default.
• W2990244562 cites W2887656622 @default.
• W2990244562 cites W2936396720 @default.
• W2990244562 doi "https://doi.org/10.1016/j.blre.2019.100647" @default.
• W2990244562 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31818701" @default.
• W2990244562 hasPublicationYear "2020" @default.
• W2990244562 type Work @default.
• W2990244562 sameAs 2990244562 @default.
• W2990244562 citedByCount "18" @default.
• W2990244562 countsByYear W29902445622020 @default.
• W2990244562 countsByYear W29902445622021 @default.
• W2990244562 countsByYear W29902445622022 @default.
• W2990244562 countsByYear W29902445622023 @default.
• W2990244562 crossrefType "journal-article" @default.
• W2990244562 hasAuthorship W2990244562A5002133396 @default.
• W2990244562 hasAuthorship W2990244562A5005922904 @default.
• W2990244562 hasAuthorship W2990244562A5028356813 @default.
• W2990244562 hasAuthorship W2990244562A5035335560 @default.
• W2990244562 hasAuthorship W2990244562A5039006383 @default.
• W2990244562 hasAuthorship W2990244562A5066768069 @default.
• W2990244562 hasAuthorship W2990244562A5071210944 @default.
• W2990244562 hasAuthorship W2990244562A5075748907 @default.
• W2990244562 hasAuthorship W2990244562A5077344066 @default.
• W2990244562 hasAuthorship W2990244562A5080599868 @default.
• W2990244562 hasAuthorship W2990244562A5085901299 @default.
• W2990244562 hasBestOaLocation W29902445622 @default.
• W2990244562 hasConcept C109159458 @default.
• W2990244562 hasConcept C114138010 @default.
• W2990244562 hasConcept C121684516 @default.
• W2990244562 hasConcept C126322002 @default.
• W2990244562 hasConcept C143998085 @default.
• W2990244562 hasConcept C203014093 @default.
• W2990244562 hasConcept C2777863708 @default.
• W2990244562 hasConcept C2778715236 @default.

• next